top of page
Actorius Innovations & Research logo
Abstract blue-green gradient with translucent cell-like circle

From cell
to certainty.

Transforming deep biological insight into precise, actionable outcomes—so decisions are made earlier, clearer, and with confidence.

Know More

OncoMetastat®

OncoMetastat® is an extracorporeal blood-processing platform engineered to selectively capture and deplete circulating tumor cells — designed to delay cancer metastasis in early stage cancers.

Book a demo

We are in pursuit of identifying and developing life-saving solutions for global healthcare problems with a focus on cancer diagnostics and cure.

Trusted by:
AQTREC logo
All India Institute of Medical Sciences seal
Tata Memorial Hospital Mumbai logo, Service, Research, Education
Tata Memorial Centre logo with medical cross, Service Research Education
MAX Healthcare logo
HCG Hospitals logo, adding life to years
Apollo Hospitals logo
Fortis logo
Multiple biological cells

11000+

Patients Served Globally

450+

Doctors Trust Us

100+

Publications

13+

Years of Excellence

Why choose us?

Our approach is grounded in rigorous research, advanced platforms, and a commitment to meaningful outcomes.

Patented Techologies

Proprietary innovations designed to deliver precision, reliability, and real-world impact.

Regulatory Approved

Regulatory-approved solutions built to meet the highest standards of safety, compliance, and clinical integrity.

ASCO AMERICAN SOCIETY OF CLINICAL ONCOLOGY
Green R with cross symbol
ISLB International Society of Liquid Biopsy logo
ESMO GOOD SCIENCE BETTER MEDICINE BEST PRACTICE

Our Publications

More than 100+ publications in

ASCO, AACR, ESMO, ISLB, etc

Read our publications

Latest from Actorius

Explore the latest updates, research perspectives, announcements, and stories shaping our work.

View all updates

The Hidden Threat of a Single Cell: Dr. Jayant Khandare on How One Circulating Tumor Cell Can Restart the Cancer Journey

May 24, 2026

Read More

ASCO 2026 : Association of circulating tumor cells with PD-L1 expression and clusters in confirmative tumor thrombus in selective solid cancers.

March 17, 2026

Read More

ASCO 26: Assessment of circulating tumor cells and clusters expressing PD-L1 in urological cancers

March 17, 2026

Read More

Actorius in Action

Stay updated with our latest events, scientific discussions, collaborations, and milestones that continue to shape the future of cancer research and innovation.

View all events
AACR 2026 - Actorius Innovations and Research

AACR 2026 Highlights | April 17-22 | San Diego, California

April 23, 2026

Read More
Meeting with Oncology KOLs in USA and Europe | Klaus Pantel , Catherine Alix, Umberto, Ravindra Kolhe

Meeting with our KOLs

February 20, 2026

Read More
Actorius ISLB 2025 | 1-3 November 2025

ISLB 2025 | 1-3 November 2025

November 3, 2025

Read More
© Copyright Actorius Innovations and Research

Frequently asked questions

Answers to commonly asked questions about Actorius and our offerings.

  • Actorius focuses on understanding cancer at the cellular level and translating that insight into precise, actionable outcomes. Our platforms are designed to look deeper, act earlier, and support more confident decisions.

  • Our solutions are built for clinicians, researchers, healthcare partners, and institutions seeking advanced tools for cancer detection, analysis, and monitoring.

  • We combine advanced biomaterials, biological insight, and data-driven analysis to study cancer behavior in detail—enabling earlier detection and more targeted intervention.

  • Our work spans both research and translational applications. Some solutions are designed for research use, while others are developed with clinical deployment in mind, subject to regulatory requirements.

  • You can explore our latest blogs, newsletters, press releases, case studies, and events in the Resources section to stay informed about our progress and insights.

Know More
bottom of page